Endophthalmitis after intravitreal injections

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Endophthalmitis following intravitreal injection is an infrequent but serious clinical problem. Infectious endophthalmitis must be differentiated from noninfectious inflammation. Depending on the series, the risk of endophthalmitis is very low. The use of a standardized injection protocol can reduce the risk of infection.

Original languageEnglish
Pages (from-to)2119-2126
Number of pages8
JournalExpert Opinion on Pharmacotherapy
Volume10
Issue number13
DOIs
StatePublished - Sep 1 2009

Fingerprint

Intravitreal Injections
Endophthalmitis
Inflammation
Injections
Infection

Keywords

  • Bevacizumab
  • Endophthalmitis
  • Intravitreal
  • Pegaptanib
  • Ranibizumab
  • Triamcinolone
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this

Endophthalmitis after intravitreal injections. / Schwartz, Stephen; Flynn, Harry W; Scott, Ingrid U.

In: Expert Opinion on Pharmacotherapy, Vol. 10, No. 13, 01.09.2009, p. 2119-2126.

Research output: Contribution to journalArticle

@article{51f7593c98a947d4b5c5d4abc909951e,
title = "Endophthalmitis after intravitreal injections",
abstract = "Endophthalmitis following intravitreal injection is an infrequent but serious clinical problem. Infectious endophthalmitis must be differentiated from noninfectious inflammation. Depending on the series, the risk of endophthalmitis is very low. The use of a standardized injection protocol can reduce the risk of infection.",
keywords = "Bevacizumab, Endophthalmitis, Intravitreal, Pegaptanib, Ranibizumab, Triamcinolone, Vascular endothelial growth factor",
author = "Stephen Schwartz and Flynn, {Harry W} and Scott, {Ingrid U.}",
year = "2009",
month = "9",
day = "1",
doi = "10.1517/14656560903081752",
language = "English",
volume = "10",
pages = "2119--2126",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Informa Healthcare",
number = "13",

}

TY - JOUR

T1 - Endophthalmitis after intravitreal injections

AU - Schwartz, Stephen

AU - Flynn, Harry W

AU - Scott, Ingrid U.

PY - 2009/9/1

Y1 - 2009/9/1

N2 - Endophthalmitis following intravitreal injection is an infrequent but serious clinical problem. Infectious endophthalmitis must be differentiated from noninfectious inflammation. Depending on the series, the risk of endophthalmitis is very low. The use of a standardized injection protocol can reduce the risk of infection.

AB - Endophthalmitis following intravitreal injection is an infrequent but serious clinical problem. Infectious endophthalmitis must be differentiated from noninfectious inflammation. Depending on the series, the risk of endophthalmitis is very low. The use of a standardized injection protocol can reduce the risk of infection.

KW - Bevacizumab

KW - Endophthalmitis

KW - Intravitreal

KW - Pegaptanib

KW - Ranibizumab

KW - Triamcinolone

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=68949141615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68949141615&partnerID=8YFLogxK

U2 - 10.1517/14656560903081752

DO - 10.1517/14656560903081752

M3 - Article

VL - 10

SP - 2119

EP - 2126

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

IS - 13

ER -